SCHEMBL5096451

SCHEMBL5096451

CN(C)C(Cl)=[N+](C)C.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.41
HTT P42858 1/20 0.40
MAPT P10636 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
GAA P10253 3/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
C5AR1 P21730 1/20 0.38
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA5B Q9Y2D0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3188751 0.83 GAA (0.42) AGERHTTMAPTMCOLN3GAA
Methyl Alcohol SCHEMBL28016005 0.73 GAA (0.56) HTTMAPTMCOLN3GAACA1
Methyl Alcohol SCHEMBL21523587 0.73 GAA (0.56) HTTMAPTMCOLN3GAACA1
Methyl Alcohol SCHEMBL3617702 0.73 GAA (0.56) HTTMAPTMCOLN3GAACA1
SCHEMBL6917586 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2
SCHEMBL20583857 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2
SCHEMBL10663598 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2
SCHEMBL22615914 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2
SCHEMBL11815250 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2
SCHEMBL8943267 0.73 GAA (0.62) MAPTMCOLN3GAACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439395-B2 Process for the preparation of guanidinium salts MERCK PATENT GMBH (DE) 2008-10-21 US claimed
US-7439395-B2 Process for the preparation of guanidinium salts MERCK PATENT GMBH (DE) 2008-10-21 US disclosed
US-20070135645-A1 Process for the preparation of guanidinium salts MERCK PATENT GMBH (DE) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135645-A1 Process for the preparation of guanidinium salts GMPS, AGPS, PFAS AGER 1862/4885HTT 1853/4885MAPT 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.